StoxEmcure Pharmaceuticals vs Aster DM Quality Care: share price & financials comparison
NSE: EMCURE vs ASTERDM · Healthcare · as of 13 Nov 2026
Both prices rebased to 100 at the start of the selected period.
Emcure Pharmaceuticals vs Aster DM Quality Care at a glance
Emcure Pharmaceuticals (EMCURE) has a market capitalisation of ₹44,804 Cr, against ₹62,979 Cr for Aster DM Quality Care (ASTERDM). Over the past year Emcure Pharmaceuticals has returned +78.3%, compared with +4.9% for Aster DM Quality Care. On valuation, Emcure Pharmaceuticals trades at a lower P/E of 41.0 versus 133.8. Emcure Pharmaceuticals earns a higher return on equity (20.5% vs 6.0%). Emcure Pharmaceuticals comes out ahead on size, valuation, profitability, financial health, momentum and technicals. Aster DM Quality Care comes out ahead on growth. Across the scored metrics below, Emcure Pharmaceuticals leads on 10 and Aster DM Quality Care on 4. On StoxGud's 10-point checklist, Emcure Pharmaceuticals scores 9/10 and Aster DM Quality Care scores 5/10.
| Metric | Emcure Pharmaceuticals | Aster DM Quality Care |
|---|---|---|
| Size | ||
| Market cap | ₹44,804 Cr | ₹62,979 Cr |
| Revenue (latest FY) | ₹9,204 Cr | ₹4,643 Cr |
| Net profit (latest FY) | ₹924 Cr | ₹388 Cr |
| Valuation | ||
| P/E | 41.0 | 133.8 |
| P/B | 8.38 | 8.08 |
| Dividend yield | 0.13% | 0.09% |
| Profitability | ||
| Return on equity | 20.5% | 6.0% |
| Net profit margin | 10.7% | 7.2% |
| Operating margin | 20.4% | 21.1% |
| Growth | ||
| Revenue growth (YoY) | +24.3% | +136.3% |
| Net profit growth (YoY) | +33.7% | +138.2% |
| Revenue CAGR (multi-year) | — | -11.6% |
| Financial health | ||
| Debt to equity | 0.27 | 0.51 |
| Momentum | ||
| 1-month return | +26.4% | +4.7% |
| 1-year return | +78.3% | +4.9% |
| 3-year CAGR | — | +28.3% |
| 5-year CAGR | — | +28.4% |
| Distance from 52W high | +0.0% | -16.9% |
| Technicals | ||
| RSI (14) | 94 | 76 |
| Price vs 200-day avg | +34.8% | +0.5% |
Highlighted cells lead on that metric. Market cap, revenue and RSI are shown for context and not scored.
10-point checklist side by side
| Check | Emcure Pharmaceuticals | Aster DM Quality Care |
|---|---|---|
| Price above 50-day average | ✓ | ✓ |
| Price above 200-day average | ✓ | ✓ |
| 50-day average above 200-day (uptrend) | ✓ | ✗ |
| RSI in healthy 40–70 zone | ✗ | ✗ |
| Positive 1-year return | ✓ | ✓ |
| Return on equity above 15% | ✓ | ✗ |
| Debt to equity below 1 | ✓ | ✓ |
| Revenue growing year on year | ✓ | ✓ |
| Net profit margin above 10% | ✓ | ✗ |
| P/E below industry median | ✓ | ✗ |
| Score | 9/10 | 5/10 |
A rules-based screen for education only — not a buy or sell recommendation.
FAQs
Which is bigger, Emcure Pharmaceuticals or Aster DM Quality Care?
Emcure Pharmaceuticals has a market cap of ₹44,804 Cr and Aster DM Quality Care has a market cap of ₹62,979 Cr as of 13 Nov 2026.
Which has a lower P/E, Emcure Pharmaceuticals or Aster DM Quality Care?
Emcure Pharmaceuticals has the lower P/E: Emcure Pharmaceuticals trades at 41.0 and Aster DM Quality Care at 133.8.
Which gave better returns in the last year, Emcure Pharmaceuticals or Aster DM Quality Care?
Emcure Pharmaceuticals did better: Emcure Pharmaceuticals returned +78.3% and Aster DM Quality Care returned +4.9% over one year.
What is the difference between Emcure Pharmaceuticals and Aster DM Quality Care?
Both are NSE-listed companies in Healthcare. They are about the same size by market cap (₹44,804 Cr vs ₹62,979 Cr). In the latest financial year Emcure Pharmaceuticals reported revenue of ₹9,204 Cr and Aster DM Quality Care ₹4,643 Cr. Operating margin is 20.4% for Emcure Pharmaceuticals and 21.1% for Aster DM Quality Care. Debt to equity is 0.27 for Emcure Pharmaceuticals and 0.51 for Aster DM Quality Care.
Which is better, Emcure Pharmaceuticals or Aster DM Quality Care?
It depends on what you are looking for, and StoxGud does not recommend either stock. On the metrics compared above, Emcure Pharmaceuticals leads on 10 and Aster DM Quality Care on 4. Emcure Pharmaceuticals is ahead on size, valuation, profitability, financial health, momentum and technicals. Aster DM Quality Care is ahead on growth. On StoxGud's rules-based checklist Emcure Pharmaceuticals scores 9/10 and Aster DM Quality Care scores 5/10. This is information, not advice: consult a SEBI-registered adviser before investing.